ABC | Volume 114, Nº4, Abril 2020

Minieditorial Martins Galectina-3 na Pericardite Constritiva Crônica Arq Bras Cardiol. 2020; 114(4):690-691 1. de Boer RA, Voors AA, Muntendam P, van Gilst WH, Veldhuisen DJ. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail. 2009;11(9):811-7. 2. de Boer RA, Daniels LB, Maisel AS, Januzzi Jr JL. State of the art: newer biomarkers in heart failure. Eur J Heart Fail. 2015;17(6):559-69. 3. Meijers WC, Januzzi JL, de Filippi C, Adourian AS, Shah SJ, van Veldhuisen DJ, de Boer RA. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials. Am Heart J. 2014;167(6):853-60. 4. de Boer RA, Edelmann F, Cohen-Solal A, Mamas MA, Maisel A, Pieske B. Galectin-3 in heart failure with preserved ejection fraction. Eur J Heart Fail. 2013;15(10):1095-101. 5. Fernandes F, deMeloDTP, Ramires FJA, Sabino EC,Moreira CHV, Benvenutti LA, et al. Galectina-3 empacientes compericardite constrictiva crônica. Arq Bras Cardiol. 2020; 114(4):683-689. 6. Fadl SA, Nasrullah A, Harris A, Edwards R, Kicska G. Comprehensive review of pericardial diseases using different imaging modalities. Int J Cardiovasc Imaging . (2020). https://doi.org/10.1007/s10554-020-01784-x 7. Maisel AS (ed.) Biomarkers for clinicians. Expert advice for clinicians. New Delhi: Jaypaee Brothers Medical Publishers Ltd; 2012. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 691